FMP

FMP

Enter

AXNX - Axonics, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/AXNX.png

Axonics, Inc.

AXNX

NASDAQ

Inactive Equity

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

70.98 USD

0 (0%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. Raymond W. Cohen

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products throu...

CIK

0001603756

ISIN

US05465P1012

CUSIP

05465P101

Address

26 Technology Drive

Phone

949 396 6322

Country

US

Employee

797

IPO Date

Oct 31, 2018

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

AXNX Financial Summary

CIK

0001603756

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

05465P101

ISIN

US05465P1012

Country

US

Price

70.98

Beta

0.83

Volume Avg.

474.46k

Market Cap

3.63B

Shares

-

52-Week

55.09-71.05

DCF

-0.19

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-709.8

P/B

-

Website

https://www.axonics.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest AXNX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep